Ukrainian Journal Health of Woman. 2025. 6(181): 63-71. doi: 10.15574/HW.2025.6(186).6371
Herevych N. V.^1,2, Koloturska Ye. O.^1,2, Batman Yu. A.^1,2, Govsieiev D. O.^1,2
¹Bohomolets National Medical University, Kyiv, Ukraine
²Kyiv Perinatal Center, Ukraine

For citation: Herevych NV, Koloturska YeO, Batman YuA, Govsieiev DO. (2025). Obstetric aspects and perinatal outcomes of pregnancy management and delivery in women with placenta previa and abnormally invasive placenta: own experience. Ukrainian Journal Health of Woman. 6(181): 63-71. doi: 10.15574/HW.2025.6(186).6371
Article received: Sep 09, 2025. Accepted for publication: Nov 20, 2025.

Placenta previa (PP) and placenta accreta spectrum (PAS) are associated with a high risk of major obstetric hemorrhage, preterm delivery, and impaired early neonatal adaptation. Data on the structure of neonatal morbidity in such pregnancies remain limited in Ukrainian tertiary care centers.
Aim – to identify the spectrum of neonatal abnormalities and transient pathological conditions in infants born from pregnancies complicated by PP and/or PAS in order to optimize neonatal care.
Materials and methods. This retrospective cohort study included 115 pregnancies complicated by PP and/or PAS that ended in planned or emergency cesarean delivery in 2020-2024. Eighty-five cases of PP and 30 cases of PAS were analyzed. Clinical and anamnestic data, intraoperative characteristics, placental pathomorphology, gestational age and birth weight, rates of admission to the neonatal intensive care unit (NICU), and neonatal morbidity patterns were assessed.
Results. PP and/or PAS were associated with increased rates of preterm birth, major obstetric hemorrhage, and impaired neonatal adaptation. In the PAS group, blood loss exceeded 1000 mL in 93% of cases, and the mean operative time was longer than in the PP group. Overall, 42 (36.5%) newborns required NICU admission; the leading indications were respiratory distress syndrome, other respiratory disorders, and transient tachypnea. Among 73 infants transferred to rooming-in care 27 (36.9%) developed transient adaptation disorders. In 2023-2024, the proportion of infants born before 28 weeks of gestation increased.
Conclusions. PP and PAS define a high-risk perinatal group due to the combination of prematurity, obstetric hemorrhage, and neonatal respiratory morbidity. Cesarean delivery at 37 weeks was not associated with severe neonatal pathology but was accompanied by maladaptation disorders, which requires readiness for early respiratory support and close neonatal monitoring.
The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Bioethics and Deontology Committee of the institution specified in this paper. Written informed consent was obtained from all participants prior to inclusion in the study.
The authors declare no conflict of interest.
Keywords: placenta previa, placenta accreta spectrum, cesarean delivery, prematurity, neonatal adaptation, respiratory disorders.

REFERENCES

1. Ahuja KB, Parveen K, Bano S, Imtiaz K, Shaikh AG, Raishem. (2024). Studying the impact of placenta previa (PP) on mothers and newborns. J Popul Ther Clin Pharmacol. 31(7): 583-589.

2. Avagliano L, Massa V, Bulfamante GP. (2011). Histology of the human placenta. In: Kay HH, Nelson DM, Wang Y, eds. The Placenta: From Development to Disease. Hoboken, NJ: Wiley-Blackwell: 1-16.

3. Becker RH, Vonk R, Mende BC, Ragosch V, Entezami M. (2001, Jun). The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol. 17(6): 496-501. https://doi.org/10.1046/j.1469-0705.2001.00423.x; PMid:11422970

4. Bi S, Zhang L, Wang Z et al. (2021). Effect of types of placenta previa on maternal and neonatal outcomes: a 10-year retrospective cohort study. Arch Gynecol Obstet. 304(1): 65-72. https://doi.org/10.1007/s00404-020-05912-9; PMid:33386958

5. Burton GJ, Fowden AL. (2015). The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 370(1663): 20140066. https://doi.org/10.1098/rstb.2014.0066; PMid:25602070 PMCid:PMC4305167

6. Fan D, Wu S, Liu LI et al. (2017). Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Sci Rep. 7: 40320. https://doi.org/10.1038/srep40320; PMid:28067303 PMCid:PMC5220286

7. Hasegawa J, Nakamura M, Hamada S et al. (2012). Prediction of hemorrhage in placenta previa. Taiwan J Obstet Gynecol. 51(1): 3-6. https://doi.org/10.1016/j.tjog.2012.01.002; PMid:22482960

8. Junejo RR, Memon N, Bai G, Shaikh AF, Dars AG, Durrani W. (2023). Impact of placenta previa on neonatal and maternal health: an analysis of complications and associated risk factors. J Soc Obstet Gynaecol Pak. 13(3): 222-227.

9. Rao J, Fan D, Zhou Z et al. (2021). Maternal and neonatal outcomes of placenta previa with and without coverage of a uterine scar: a retrospective cohort study in a tertiary hospital. Int J Womens Health. 13: 671-681. https://doi.org/10.2147/IJWH.S310097; PMid:34262357 PMCid:PMC8273910

10. Rathbun KM, Hildebrand JP. (2018). Placenta abnormalities. In: StatPearls. Treasure Island (FL): StatPearls Publishing.

11. Ruiter L, Kok N, Limpens J et al. (2016). Incidence of and risk indicators for vasa praevia: a systematic review. BJOG. 123(8): 1278-1287. https://doi.org/10.1111/1471-0528.13829; PMid:26694639

12. Schoenfisch AL, Dement JM, Rodriguez-Acosta RL. (2008). Demographic, clinical and occupational characteristics associated with early onset of delivery: findings from the Duke Health and Safety Surveillance System, 2001-2004. Am J Ind Med. 51(11): 911-922. https://doi.org/10.1002/ajim.20637; PMid:18942663

13. Silver RM. (2015). Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 126(3): 654-668. https://doi.org/10.1097/AOG.0000000000001005; PMid:26244528

14. Vahanian SA, Lavery JA, Ananth CV, Vintzileos A. (2015). Placental implantation abnormalities and risk of preterm delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 213; 4 Suppl: S78-S90. https://doi.org/10.1016/j.ajog.2015.05.058; PMid:26428506